Sign in to view content

Treat-and-Extend Versus Bimonthly Dosing With Aflibercept for the Treatment of Diabetic Macular Edema, 1-Year Outcomes (EVADE Study)

Dilsher S. Dhoot, MD

Video
Published 2018

Related

Masked Safety Data from ZETA-1, an Ongoing 24-Week Phase 2 Clinical Trial of APX3330, an Oral Therapeutic Being Developed for the Treatment of Diabetic Retinopathy
Michael J Allingham, MD, PhD
Annual Meeting Talks
2022
Correlation of Peripheral Nonperfusion on Ultra-widefield Fluorescein Angiography with Macular Flow Loss on OCT Angiography in Sickle Cell Retinopathy
Adrienne W. Scott, MD, FASRS
Annual Meeting Talks
2018
Is It Necessary to Peel Internal Limiting Membrane in Diabetic Vitrectomy
Stanley Chang, MD
Updates from the Field
2022

Category: Diabetic Retinopathy

See more